Management of pathologic fractures of the proximal femur - State of the art

被引:77
作者
Jacofsay, DJ
Haidukewych, GJ
机构
[1] Mayo Clin, Orthoped Trauma Serv, Rochester, MN 55905 USA
[2] Mayo Clin, Div Orthoped Oncol, Rochester, MN 55905 USA
关键词
pathologic; femur; hip; fracture; metastasis;
D O I
10.1097/00005131-200408000-00013
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Metastases to bone are the most common cause of a destructive lesion of the skeleton in an adult. The proximal femur is the most commonly affected bone with metastatic disease in the appendicular skeleton. A systematic approach to patient management is critical, so as to avoid complications that will delay systemic therapy. The orthopedic traumatologist is often the first physician to see the patient with a pathologic fracture. As a result, the surgeon must be aware of the indications for resection versus internal fixation, as well as options for reconstruction. Polymethyl methacrylate and curettage can be useful in the appropriately selected patient. Postoperative external beam irradiation can significantly reduce disease progression and subsequent loss of fixation. A multidisciplinary approach to this patient group will help optimize prognosis as well as function. This article reviews the evaluation, management, and complications of treatment of pathologic fractures of the proximal femur, with an emphasis on metastatic disease and multiple myeloma.
引用
收藏
页码:459 / 469
页数:11
相关论文
共 43 条
[1]  
Althausen P, 1997, CANCER, V80, P1103
[2]  
[Anonymous], 1999, CANC FACTS FIG 1999, P1
[3]  
BEALS RK, 1971, CANCER, V28, P1350, DOI 10.1002/1097-0142(1971)28:5<1350::AID-CNCR2820280539>3.0.CO
[4]  
2-6
[5]  
Blamey R, 1999, EUR J SURG ONCOL, V25, P3
[6]  
BURNSTEIN AH, 1972, J BONE JOINT SURG AM, V54, P1143
[7]  
CAPANNA R, 1991, COMPLICATIONS LIMB S
[8]   Head and neck replacement endoprostheses for pathologic proximal femoral lesions [J].
Clarke, HD ;
Damron, TA ;
Sim, FH .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1998, (353) :210-217
[9]  
Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO
[10]  
2-Z